Reuters: Hot Stocks: BRIEF-Peregrine Pharma surges after non-small cell lung cancer trial results

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Peregrine Pharma surges after non-small cell lung cancer trial results Sep 7th 2012, 17:34 NEW YORK, Sept 7 | Fri Sep 7, 2012 1:34pm EDT NEW YORK, Sept 7 (Reuters) - Peregrine Pharmaceuticals Inc : * Pharma surges 56.4 percent to $4.80 after non-small cell lung cancer trial results

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions